Celeris Therapeutics is a deep learning company that uses innovative, computer-based methods to degrade undruggable targets. Founded by Christopher Trummer in 2021, Celeris Therapeutics is backed by APEX Ventures, R42 Group, and Longevitytech.fund and is headquartered in Graz.